Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Naresh Mandava

Concepts (376)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Macular Degeneration
24
2025
186
5.620
 Why?
Geographic Atrophy
13
2026
91
4.290
 Why?
Wet Macular Degeneration
8
2025
57
2.770
 Why?
Tomography, Optical Coherence
18
2025
257
2.620
 Why?
Visual Acuity
21
2025
447
2.260
 Why?
Fluorescein Angiography
20
2025
175
2.120
 Why?
Retinal Detachment
6
2023
74
1.960
 Why?
Diabetic Retinopathy
11
2023
201
1.750
 Why?
Retinal Drusen
4
2024
31
1.730
 Why?
Angiogenesis Inhibitors
17
2023
230
1.660
 Why?
Registries
9
2025
2144
1.620
 Why?
Choroid
7
2025
78
1.500
 Why?
Complement Activation
5
2025
415
1.220
 Why?
Vitreous Body
16
2022
122
1.120
 Why?
Vitrectomy
12
2020
78
1.030
 Why?
Multimodal Imaging
2
2025
120
1.010
 Why?
Macula Lutea
2
2023
22
0.980
 Why?
Vascular Endothelial Growth Factor A
13
2024
554
0.970
 Why?
Complement System Proteins
3
2025
333
0.930
 Why?
Retina
10
2021
314
0.840
 Why?
Aged, 80 and over
22
2025
7923
0.840
 Why?
Retinal Diseases
4
2023
96
0.780
 Why?
Antibodies, Monoclonal
9
2011
1474
0.750
 Why?
Biomarkers
8
2025
4190
0.740
 Why?
Retinal Neovascularization
2
2019
28
0.720
 Why?
Choroidal Neovascularization
6
2019
57
0.700
 Why?
National Eye Institute (U.S.)
1
2020
6
0.690
 Why?
Aged
35
2025
24746
0.680
 Why?
Follow-Up Studies
17
2025
5212
0.670
 Why?
Retinal Perforations
4
2015
19
0.660
 Why?
Quarantine
1
2020
31
0.650
 Why?
Estrogen Replacement Therapy
1
2019
142
0.580
 Why?
Retinopathy of Prematurity
4
2024
161
0.570
 Why?
Retinitis Pigmentosa
3
2021
20
0.570
 Why?
Fundus Oculi
8
2026
86
0.550
 Why?
Humans
87
2026
141754
0.520
 Why?
Female
55
2025
75943
0.510
 Why?
Epiretinal Membrane
3
2010
8
0.510
 Why?
Intraocular Pressure
6
2012
315
0.500
 Why?
Automobile Driving
1
2018
152
0.500
 Why?
Fovea Centralis
3
2025
23
0.490
 Why?
Male
53
2025
70179
0.490
 Why?
Scleral Buckling
3
2019
18
0.470
 Why?
Proliferating Cell Nuclear Antigen
2
2007
53
0.460
 Why?
Vitreoretinopathy, Proliferative
2
2007
14
0.460
 Why?
Optic Neuropathy, Ischemic
3
2013
31
0.430
 Why?
RNA, Catalytic
2
2007
189
0.430
 Why?
Self Report
1
2018
861
0.420
 Why?
Recombinant Fusion Proteins
4
2013
674
0.410
 Why?
Middle Aged
34
2025
34647
0.400
 Why?
Antibodies, Monoclonal, Humanized
11
2015
913
0.400
 Why?
Optic Disk
4
2025
52
0.400
 Why?
Prospective Studies
9
2025
7777
0.400
 Why?
Surveys and Questionnaires
5
2025
5974
0.390
 Why?
Bevacizumab
11
2015
139
0.380
 Why?
Research Design
1
2019
1146
0.380
 Why?
Retrospective Studies
26
2025
16374
0.370
 Why?
Retinal Necrosis Syndrome, Acute
2
2013
7
0.370
 Why?
Retinal Vein Occlusion
2
2015
13
0.370
 Why?
Image Processing, Computer-Assisted
3
2026
774
0.360
 Why?
Pandemics
1
2020
1656
0.360
 Why?
Photography
4
2015
115
0.360
 Why?
Retinal Pigment Epithelium
3
2024
77
0.350
 Why?
Uveal Diseases
2
2013
6
0.350
 Why?
Endophthalmitis
3
2017
45
0.350
 Why?
Disease Progression
6
2025
2800
0.340
 Why?
Cross-Sectional Studies
8
2025
5697
0.340
 Why?
Colorado
8
2025
4629
0.340
 Why?
Cataract
2
2020
223
0.340
 Why?
Diagnostic Techniques, Ophthalmological
2
2015
50
0.320
 Why?
Complement Factor B
2
2022
110
0.320
 Why?
Glycogen Storage Disease Type IIb
2
2007
24
0.310
 Why?
Visual Fields
3
2022
115
0.310
 Why?
Vision, Low
4
2022
17
0.300
 Why?
Pigment Epithelium of Eye
2
2006
36
0.300
 Why?
Injections
6
2010
191
0.300
 Why?
Ophthalmology
2
2013
105
0.280
 Why?
Risk Factors
11
2025
10482
0.280
 Why?
Ocular Hypertension
1
2009
67
0.280
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1406
0.280
 Why?
Phacoemulsification
3
2020
120
0.270
 Why?
Macular Edema
2
2015
46
0.270
 Why?
Encephalitis, Herpes Simplex
1
2007
21
0.260
 Why?
Optic Nerve Injuries
1
2007
9
0.260
 Why?
Quantum Dots
2
2021
38
0.260
 Why?
Glaucoma
3
2025
241
0.260
 Why?
von Hippel-Lindau Disease
1
2007
12
0.260
 Why?
Papilledema
1
2007
42
0.260
 Why?
Glucocorticoids
2
2013
534
0.260
 Why?
Vision Disorders
2
2022
168
0.260
 Why?
Puerperal Disorders
1
2007
33
0.250
 Why?
Triamcinolone Acetonide
1
2006
19
0.250
 Why?
Herpesvirus 1, Human
1
2007
81
0.250
 Why?
Ocular Hypotension
1
2006
10
0.250
 Why?
Ciliary Body
1
2006
40
0.240
 Why?
Myopia
1
2006
55
0.240
 Why?
Telangiectasis
1
2005
8
0.240
 Why?
Granuloma
1
2006
97
0.230
 Why?
Chemokine CCL5
2
2023
43
0.230
 Why?
Time Factors
5
2025
6966
0.230
 Why?
Optical Imaging
1
2026
66
0.230
 Why?
DNA, Viral
1
2007
367
0.230
 Why?
Retinal Vessels
1
2005
75
0.220
 Why?
Retinal Ganglion Cells
4
2022
117
0.220
 Why?
Laser Therapy
2
2021
128
0.210
 Why?
Birth Weight
2
2024
515
0.210
 Why?
Diseases in Twins
1
2024
159
0.210
 Why?
Vision Tests
1
2023
19
0.210
 Why?
Diabetes Mellitus
2
2023
1077
0.210
 Why?
Fluorocarbons
1
2005
134
0.210
 Why?
Temporal Arteries
2
2015
44
0.210
 Why?
Twins
1
2024
225
0.200
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2013
109
0.200
 Why?
Hemianopsia
1
2022
11
0.190
 Why?
Disease Models, Animal
4
2012
4421
0.190
 Why?
Ophthalmoscopy
2
2015
38
0.180
 Why?
Posterior Capsulotomy
1
2021
7
0.180
 Why?
Posterior Capsule of the Lens
1
2021
11
0.180
 Why?
Capsule Opacification
1
2021
22
0.170
 Why?
Lasers, Solid-State
1
2021
23
0.170
 Why?
Artificial Intelligence
1
2025
337
0.170
 Why?
Ranibizumab
5
2013
21
0.170
 Why?
Sickness Impact Profile
1
2020
58
0.170
 Why?
Posterior Capsular Rupture, Ocular
1
2020
6
0.170
 Why?
Herpesvirus 3, Human
2
2015
336
0.160
 Why?
Nerve Fibers
2
2010
100
0.160
 Why?
Reproducibility of Results
3
2025
3356
0.160
 Why?
Neurodegenerative Diseases
1
2022
141
0.160
 Why?
Machine Learning
1
2026
556
0.160
 Why?
Electrodes, Implanted
2
2018
113
0.160
 Why?
Intravitreal Injections
6
2020
60
0.160
 Why?
Protective Factors
1
2019
96
0.150
 Why?
Odds Ratio
2
2019
1057
0.150
 Why?
Complement Membrane Attack Complex
1
2019
38
0.150
 Why?
Ischemia
2
2017
415
0.150
 Why?
Complement C3a
1
2019
42
0.150
 Why?
C-Reactive Protein
1
2021
424
0.150
 Why?
Intraoperative Complications
1
2020
148
0.150
 Why?
Visual Prosthesis
1
2018
1
0.150
 Why?
Cohort Studies
5
2020
5815
0.140
 Why?
Metformin
1
2021
333
0.130
 Why?
Orbit
2
2010
71
0.130
 Why?
Quality of Life
4
2022
3014
0.130
 Why?
Anterior Eye Segment
1
2017
11
0.130
 Why?
Labor, Induced
1
2017
36
0.130
 Why?
Gestational Age
4
2024
959
0.130
 Why?
Postoperative Complications
3
2021
2821
0.130
 Why?
Labor, Obstetric
1
2017
67
0.130
 Why?
Giant Cell Arteritis
2
2015
48
0.130
 Why?
Laser Coagulation
3
2012
71
0.130
 Why?
Strabismus
1
2017
65
0.120
 Why?
Ophthalmologic Surgical Procedures
1
2017
84
0.120
 Why?
Retinal Degeneration
2
2015
39
0.120
 Why?
Blindness
3
2013
49
0.120
 Why?
Gyrate Atrophy
1
2015
2
0.120
 Why?
Phenotype
3
2022
3177
0.120
 Why?
Recovery of Function
1
2019
684
0.120
 Why?
Vitreoretinal Surgery
1
2015
5
0.120
 Why?
Multivariate Analysis
1
2019
1498
0.120
 Why?
Case-Control Studies
2
2020
3597
0.110
 Why?
Incidence
2
2020
2806
0.110
 Why?
Immunosuppressive Agents
2
2013
855
0.110
 Why?
Vitreous Detachment
1
2015
9
0.110
 Why?
Needles
1
2015
63
0.110
 Why?
Encephalitis, Varicella Zoster
1
2015
17
0.110
 Why?
Eye Infections, Bacterial
1
2015
45
0.110
 Why?
Biopsy, Needle
1
2015
187
0.110
 Why?
Antiviral Agents
2
2013
747
0.110
 Why?
Rats, Inbred BN
3
2011
56
0.110
 Why?
Logistic Models
1
2019
2092
0.110
 Why?
Proteins
1
2020
1015
0.110
 Why?
Treatment Outcome
7
2021
11181
0.110
 Why?
Wounds, Gunshot
2
2010
248
0.110
 Why?
Inflammation
3
2023
2902
0.110
 Why?
Oculomotor Muscles
1
2014
75
0.110
 Why?
Anti-Inflammatory Agents
2
2021
482
0.100
 Why?
Exchange Transfusion, Whole Blood
1
2013
16
0.100
 Why?
Uvea
1
2013
4
0.100
 Why?
Drug Packaging
2
2011
43
0.100
 Why?
Uveomeningoencephalitic Syndrome
1
2013
8
0.100
 Why?
Retinal Artery Occlusion
1
2013
10
0.100
 Why?
Drug Resistance, Multiple, Viral
1
2013
10
0.100
 Why?
Fibrin
1
2014
91
0.100
 Why?
Proteomics
1
2020
1138
0.100
 Why?
Tendons
1
2014
123
0.100
 Why?
Cytomegalovirus Retinitis
1
2013
21
0.100
 Why?
Isoxazoles
1
2013
54
0.100
 Why?
Lymphoproliferative Disorders
1
2013
60
0.100
 Why?
Premature Birth
1
2017
368
0.100
 Why?
Silicon
1
2012
21
0.100
 Why?
Fatty Acids, Omega-3
1
2014
142
0.100
 Why?
Lens Subluxation
1
2012
4
0.090
 Why?
Adult
15
2020
39391
0.090
 Why?
Trabecular Meshwork
1
2013
79
0.090
 Why?
Viremia
1
2013
150
0.090
 Why?
Exanthema
1
2013
81
0.090
 Why?
Uveitis, Posterior
1
2012
12
0.090
 Why?
Diagnostic Imaging
1
2015
327
0.090
 Why?
Fluocinolone Acetonide
1
2012
15
0.090
 Why?
Diagnosis, Differential
4
2013
1502
0.090
 Why?
Microsurgery
1
2012
78
0.090
 Why?
Electric Stimulation Therapy
1
2012
81
0.090
 Why?
Placenta
1
2018
769
0.090
 Why?
Vascular Endothelial Growth Factors
1
2011
80
0.090
 Why?
Fluorescein-5-isothiocyanate
2
2009
38
0.090
 Why?
Electroretinography
2
2012
51
0.090
 Why?
Drug Storage
1
2011
53
0.080
 Why?
Global Health
1
2014
387
0.080
 Why?
Silicone Oils
1
2011
32
0.080
 Why?
Dextrans
2
2009
85
0.080
 Why?
Particulate Matter
2
2011
330
0.080
 Why?
Dissection
1
2011
55
0.080
 Why?
Health Care Costs
1
2014
427
0.080
 Why?
Antioxidants
1
2014
599
0.080
 Why?
Infliximab
2
2007
111
0.080
 Why?
Lysosomal-Associated Membrane Protein 2
2
2007
29
0.080
 Why?
Protein Multimerization
1
2011
194
0.080
 Why?
Anemia, Sickle Cell
1
2013
268
0.080
 Why?
Clinical Trials, Phase II as Topic
1
2009
76
0.080
 Why?
Clinical Trials, Phase I as Topic
1
2009
53
0.080
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
454
0.080
 Why?
Tonometry, Ocular
1
2009
103
0.070
 Why?
Herpes Zoster
1
2013
319
0.070
 Why?
Bacteria
1
2015
881
0.070
 Why?
United States
3
2020
15310
0.070
 Why?
Scotoma
1
2008
7
0.070
 Why?
Rats
4
2012
5637
0.070
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
255
0.070
 Why?
Retinal Artery
1
2007
17
0.070
 Why?
Vitreous Hemorrhage
1
2007
9
0.070
 Why?
Cerebral Angiography
1
2007
115
0.070
 Why?
RNA, Messenger
2
2007
2828
0.070
 Why?
Acyclovir
1
2007
95
0.060
 Why?
Dose-Response Relationship, Drug
2
2009
2064
0.060
 Why?
Frameshift Mutation
1
2006
32
0.060
 Why?
Conjunctival Neoplasms
1
2005
8
0.060
 Why?
Secondary Prevention
1
2007
241
0.060
 Why?
Ultrasonography
2
2007
761
0.060
 Why?
Internationality
2
2018
158
0.060
 Why?
Indocyanine Green
1
2005
41
0.060
 Why?
Eye Injuries, Penetrating
1
2005
20
0.060
 Why?
Animals
7
2014
37749
0.060
 Why?
Eye Foreign Bodies
1
2005
26
0.060
 Why?
beta-Thalassemia
1
2006
37
0.060
 Why?
Coloring Agents
1
2005
96
0.060
 Why?
Eye Injuries
1
2006
53
0.060
 Why?
Staining and Labeling
1
2005
154
0.060
 Why?
Tumor Necrosis Factor-alpha
2
2007
1250
0.060
 Why?
Uncertainty
1
2026
139
0.060
 Why?
Infant, Newborn
3
2024
6289
0.060
 Why?
Antihypertensive Agents
1
2009
508
0.060
 Why?
Uveitis
1
2006
148
0.060
 Why?
Mydriatics
1
2004
9
0.060
 Why?
Metals
1
2005
140
0.050
 Why?
Pupil
1
2004
22
0.050
 Why?
Pregnancy
3
2018
7092
0.050
 Why?
Sclera
2
2014
38
0.050
 Why?
Polymerase Chain Reaction
1
2007
1056
0.050
 Why?
Hospitals, County
1
2023
11
0.050
 Why?
Cardiomyopathy, Dilated
1
2007
340
0.050
 Why?
Sensitivity and Specificity
2
2008
1977
0.050
 Why?
Observer Variation
1
2004
357
0.050
 Why?
Fibroblasts
2
2013
1021
0.050
 Why?
Enzyme-Linked Immunosorbent Assay
2
2019
855
0.050
 Why?
Chimera
1
2002
61
0.050
 Why?
Enzyme Stability
1
2002
71
0.050
 Why?
Interleukin-4
1
2023
215
0.050
 Why?
Double-Blind Method
1
2007
1989
0.050
 Why?
Young Adult
6
2019
13749
0.050
 Why?
Complement Factor I
1
2022
12
0.050
 Why?
Endopeptidases
1
2002
86
0.050
 Why?
Preventive Medicine
1
2002
40
0.050
 Why?
Aqueous Humor
1
2022
38
0.050
 Why?
Blood
1
2002
113
0.050
 Why?
Autoimmune Diseases
1
2006
465
0.050
 Why?
Coculture Techniques
1
2002
245
0.050
 Why?
Albumins
1
2022
116
0.040
 Why?
Retreatment
2
2012
73
0.040
 Why?
Rabbits
1
2002
754
0.040
 Why?
Fibrinogen
1
2022
180
0.040
 Why?
Lenses, Intraocular
1
2021
45
0.040
 Why?
Cells, Cultured
2
2013
4212
0.040
 Why?
Cell Division
1
2002
798
0.040
 Why?
Equipment Design
2
2014
525
0.040
 Why?
Drug Compounding
2
2011
104
0.040
 Why?
Electric Stimulation
1
2021
281
0.040
 Why?
Immunologic Factors
1
2022
249
0.040
 Why?
Chronic Disease
1
2006
1820
0.040
 Why?
Cell Survival
2
2013
1134
0.040
 Why?
Postoperative Period
1
2019
361
0.040
 Why?
Melanoma
1
2005
792
0.040
 Why?
Immunity, Maternally-Acquired
1
2018
19
0.040
 Why?
Combined Modality Therapy
2
2013
1249
0.030
 Why?
Infant
3
2020
9843
0.030
 Why?
Lipids
1
2002
690
0.030
 Why?
Prevalence
2
2015
2799
0.030
 Why?
Primary Health Care
1
2008
1809
0.030
 Why?
Iris Diseases
1
2017
8
0.030
 Why?
Choroid Diseases
1
2017
11
0.030
 Why?
Longitudinal Studies
1
2025
2938
0.030
 Why?
Parity
1
2017
110
0.030
 Why?
Prosthesis Implantation
1
2018
157
0.030
 Why?
Referral and Consultation
1
2022
799
0.030
 Why?
Infant, Low Birth Weight
1
2017
146
0.030
 Why?
Sex Characteristics
1
2022
792
0.030
 Why?
Mental Health
1
2022
759
0.030
 Why?
Microbiological Techniques
1
2015
33
0.030
 Why?
Risk
1
2018
907
0.030
 Why?
Endotamponade
1
2015
3
0.030
 Why?
Colony Count, Microbial
1
2015
123
0.030
 Why?
Myopia, Degenerative
1
2015
4
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
33
0.030
 Why?
Cerebral Arterial Diseases
1
2015
50
0.030
 Why?
Conjunctiva
1
2014
53
0.030
 Why?
Atrophy
1
2015
197
0.030
 Why?
Biometry
1
2014
70
0.030
 Why?
Lens Implantation, Intraocular
1
2015
67
0.030
 Why?
Adolescent
3
2012
22130
0.030
 Why?
Fetus
1
2018
802
0.030
 Why?
Early Diagnosis
1
2014
244
0.030
 Why?
T-Lymphocytes
1
2022
2007
0.020
 Why?
Safety-net Providers
1
2014
124
0.020
 Why?
Adaptation, Ocular
1
2012
6
0.020
 Why?
Dark Adaptation
1
2012
13
0.020
 Why?
Rats, Mutant Strains
1
2012
24
0.020
 Why?
Sclerostomy
1
2012
4
0.020
 Why?
Infant, Premature
1
2017
598
0.020
 Why?
Cytomegalovirus
1
2013
163
0.020
 Why?
Child, Preschool
1
2007
11512
0.020
 Why?
Hypoglycemic Agents
1
2021
1374
0.020
 Why?
Cell Count
1
2012
326
0.020
 Why?
Mothers
1
2018
785
0.020
 Why?
Drug Implants
1
2012
83
0.020
 Why?
Bruch Membrane
1
2011
6
0.020
 Why?
Gold
1
2012
119
0.020
 Why?
Swine
1
2014
812
0.020
 Why?
Polyglycolic Acid
1
2011
44
0.020
 Why?
Miniaturization
1
2011
22
0.020
 Why?
Administration, Oral
1
2013
803
0.020
 Why?
Drug Stability
1
2011
166
0.020
 Why?
Delayed-Action Preparations
1
2011
177
0.020
 Why?
Chromatography, Gel
1
2010
131
0.020
 Why?
Immunoglobulin Light Chains
1
2010
51
0.020
 Why?
Fluorescein
1
2010
24
0.020
 Why?
Immunoglobulin Heavy Chains
1
2010
85
0.020
 Why?
Molecular Weight
1
2010
329
0.020
 Why?
Comorbidity
1
2015
1664
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2010
336
0.020
 Why?
Microfluidic Analytical Techniques
1
2010
81
0.020
 Why?
Aptamers, Nucleotide
1
2010
85
0.020
 Why?
Lactic Acid
1
2011
303
0.020
 Why?
Particle Size
1
2011
404
0.020
 Why?
Reference Values
1
2010
807
0.020
 Why?
Poverty Areas
1
2008
41
0.020
 Why?
Community Health Centers
1
2008
63
0.020
 Why?
Fluorescent Dyes
1
2010
324
0.020
 Why?
Optic Nerve Diseases
1
2008
47
0.020
 Why?
Kaplan-Meier Estimate
1
2010
910
0.020
 Why?
Models, Biological
1
2015
1828
0.020
 Why?
Kidney Transplantation
1
2013
678
0.020
 Why?
Pilot Projects
1
2012
1826
0.020
 Why?
Imaging, Three-Dimensional
1
2010
569
0.020
 Why?
Polyethylene Glycols
1
2011
641
0.020
 Why?
Pedigree
1
2007
511
0.010
 Why?
Infusions, Intravenous
1
2006
417
0.010
 Why?
Anti-Bacterial Agents
1
2015
1866
0.010
 Why?
Adrenal Cortex Hormones
1
2008
501
0.010
 Why?
Severity of Illness Index
1
2011
2903
0.010
 Why?
Mass Screening
1
2008
1313
0.010
 Why?
Tomography, X-Ray Computed
1
2010
2765
0.010
 Why?
Risk Assessment
1
2008
3508
0.010
 Why?
Diabetes Mellitus, Type 2
1
2012
2537
0.010
 Why?
Aging
1
2008
1924
0.010
 Why?
Mutation
1
2007
4015
0.010
 Why?
Child
1
2012
22414
0.010
 Why?
Mandava's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (376) concept(s)
_
Co-Authors Expand Description
See all (53) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)